Related Articles
miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor
miR‑223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin‑like growth factor‑1 receptor and cyclin-dependent kinase 2
Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway
MicroRNA-223 affects IL-6 secretion in mast cells via the IGF1R/PI3K signaling pathway
Insulin-like growth factor 1 receptor-mediated cell survival in hypoxia depends on the promotion of autophagy via suppression of the PI3K/Akt/mTOR signaling pathway